Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,045 | -$61,618 | -$62,493 | -$77,702 |
| Dep. & Amort. | $3,421 | $3,254 | $3,000 | $2,518 |
| Deferred Tax | $0 | $0 | $0 | -$5,626 |
| Stock-Based Comp. | $4,382 | $5,387 | $10,625 | $22,047 |
| Change in WC | $2,590 | $4,932 | $2,253 | -$102 |
| Other Non-Cash | $15,458 | $7,849 | -$2,113 | $11,542 |
| Operating Cash Flow | -$24,194 | -$40,196 | -$48,728 | -$47,323 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$509 | -$1,035 | -$554 | -$603 |
| Net Acquisitions | $0 | $0 | $554 | $603 |
| Inv. Purchases | $0 | $0 | -$27,506 | -$30,081 |
| Inv. Sales/Matur. | $0 | $9,695 | $40,477 | $38,988 |
| Other Inv. Act. | $0 | $0 | -$554 | -$603 |
| Investing Cash Flow | -$509 | $8,660 | $12,417 | $8,304 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,449 | $8,750 | -$1,281 | -$360 |
| Stock Issued | $29,982 | $4,000 | $32,872 | $42,880 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,480 | -$3,731 | $39 | $706 |
| Financing Cash Flow | $27,053 | $9,019 | $31,630 | $43,226 |
| Forex Effect | $610 | -$250 | -$312 | -$90 |
| Net Chg. in Cash | $2,960 | -$22,767 | -$4,993 | $4,117 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,138 | $34,905 | $39,898 | $35,781 |
| End Cash | $15,098 | $12,138 | $34,905 | $39,898 |
| Free Cash Flow | -$24,703 | -$41,231 | -$49,282 | -$47,926 |